To confirm the expression and function of platelet mRNA CCR7 and FAM102A in glioma patients, we used the GEPIA [26] to analyze the expression levels of CCR7 and FAM102A in GBM and its subtypes by integrating TCGA and GTX data (|log2FC|cut off > 1, P cutoff < 0.01) in Figures 7(a)–7(d). This evidence concerns the gene CCR7 and central nervous system cancer.